Concepedia

Ralph Bennett

RB

Statistics

Publications

4

Citations

508

H-Index

4

Active since

2003

Affiliations

Horizon Therapeutics (United States)(Current)

Arthritis Northwest

Brigham and Women's Hospital

Arthritis and Rheumatism Associates

Alaska Neurology Center

Ralph Bennett is an author at Horizon Therapeutics (United States) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

2003–2022

4

Publications

4

Anakinra, a recombinant human interleukin‐1 receptor antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo‐controlled trial

Roy Fleischmann, Joy Schechtman, Ralph Bennett et al. · Arthritis & Rheumatism · 2003 · 394 citations

, , +17

Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR)

John K. Botson, John Tesser, Ralph Bennett et al. · The Journal of Rheumatology · 2020 · 65 citations · Full text

, , +9

Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.

John Tesser, Roy Fleischmann, Robin K. Dore et al. · PubMed · 2004 · 39 citations

, , +17

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study

John K. Botson, John Tesser, Ralph Bennett et al. · Arthritis Research & Therapy · 2022 · 10 citations · Full text

, , +14

1–4 of 4